Bladder cancer discovered by ovarian metastasis: Cytokeratin expression is useful when making differential diagnosis
Authors:
Open Access
- 17 January 2005
- journal article
- case report
- Published by Wiley in International Journal of Urology
- Vol. 12 (1) , 104-107
Abstract
A 49‐year‐old woman underwent hysterectomy and bilateral adnexectomy after the diagnosis of a right ovarian tumor with paraaortic and pelvic lymph node metastases. The pathological diagnosis was undifferentiated carcinoma of the ovary. After the operation, a bladder tumor was discovered during the evaluation for microscopic hematuria. The bladder tumor was pathologically diagnosed as transitional cell carcinoma, pT1b, G3. Although the pathological findings of the bladder cancer and ovarian cancer were very similar, we could diagnose primary bladder cancer with ovary and lymph node metastases according to the immunohistochemical staining pattern of cytokeratins 7 and 20. Herein, the clinical usefulness of immunohistochemical staining using cytokeratins for making a differential diagnosis of the origin of a tumor in the pelvic cavity is demonstrated.Keywords
This publication has 7 references indexed in Scilit:
- Transitional cell carcinomas of the ovary and bladder are immunophenotypically differentHistopathology, 2000
- Phase II Study of Cisplatin and Paclitaxel in Advanced Carcinoma of the Urothelium: An Eastern Cooperative Oncology Group StudyJournal of Clinical Oncology, 2000
- Metastatic Transitional Cell Carcinoma of the Ovary from Superficial Bladder TumourScandinavian Journal of Urology and Nephrology, 1998
- Transitional Cell Neoplasms of the Ovary and Urinary Bladder: A Comparative Immunohistochemical AnalysisInternational Journal of Gynecological Pathology, 1996
- Ovarian Carcinomas with Transitional Cell Carcinoma PatterAmerican Journal of Clinical Pathology, 1990
- Secondary ovarian neoplasia. A clinicopathologic study of 35 casesCancer, 1984
- Metastases from transitional cell carcinoma of urinary bladderUrology, 1980